New Oral Weight-Loss Drug Offers Effective Results Without Common Side Effects
A new oral drug targeting the β2-adrenergic receptor shows promise as a safer alternative to Ozempic for treating type 2 diabetes and obesity, with potential benefits including muscle growth and fewer side effects, currently in phase 2 clinical trials.